Company CVAbout BDH Industries Ltd 
BDH Industries Ltd
Micro Cap
Pharmaceuticals & Drugs
Incorporated in 1990 as a private limited company, BDH Industries (BDHIL) was converted into a public limited company in 1994. It was established to take over a going concern, Bombay Drug House Pvt Ltd. This company was amalgamated with BDHIL in 1994 and, since then, it has been manufacturing a wide range of drug formulations in the antibiotic, anti-inflamatory and anti-microbial segments. The Company is engaged in manufacturing of therapeutic formulations covering wide range of pharmaceuticals.
Company Coordinates
Company Details
Nair Baug, Akurli Road Kandivli (E) Mumbai Maharashtra : 400101
Registrar Details
TSR Darashaw Ltd, 6-10 , Haji Moosa Patrawala Indl. Est , 20 Dr.E.Moses Road , Mahalaxmi , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
No Details Available.
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 1 FIIs (0.28%)
Promoter with highest holding
Jayashree Nair (21.83%)
Highest Public shareholder
Vramath Financial Services Pvt. Ltd (5.59%)
Individual Investors Holdings
28.99%
Board of Directors
Management
Designation
Remuneration
Jayashree Nair
Chairperson & Managing Direct
1.11 cr
S C Kachhara
Joint Managing Director & CFO
1.11 cr
Karthika Nair
Director
82.5 k
Dinesh Variar
Independent Director
1.32 lacs
Bhagirath Singh Sihag
Independent Director
1.43 lacs
Nikita Phatak
Company Sec. & Compli. Officer
0
Kairav Trivdi
Independent Director
1.43 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of material Consumed
30.3337
0%
Cost of material Consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Miscellaneous Income
0.31
0.60%
Miscellaneous Income
Miscellaneous Income
Stock DNARevenue and Profits:
Net Sales:
16 Cr
(Quarterly Results - Dec 2024)
Net Profit:
3 Cr
Pharmaceuticals & Drugs
INR 150 Cr (Micro Cap)
16.00
33
1.67%
-0.37
15.34%
2.44
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
